findmyKOL

Charles Prince, MD

Basic profile

University of Louisville

ORCIDNone on fileNPI↗
✓ Full record
RegionLouisville, KY · SoutheastSpecialtyInterventional CardiologyFocusCardiology
Last active 2024findmyKOL type: RegionalLatest publication2003Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Charles Prince is a Cardiology physician affiliated with University of Louisville. OpenAlex indexes 20 publications with 1,113 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
20publications

Distinct works indexed by OpenAlex.

1,113citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
21companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1900 Bluegrass Ave
Suite 103
Louisville, KY 402151144

Telephone

502-367-4500

Registry record last updated 8 Mar 2018.

View the NPPES registry record

Industry payments

21 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    72.8%
    Beta blocker22.9%
    Metoprolol Succinate47%Carvedilol23%Metoprolol Tartrate19%Sotalol7%Atenolol4%
    Part D<11 patients
    Angiotensin receptor-neprilysin inhibitor (ARNI)7.6%
    Entresto100%
    Part D≥33 patients

    + 13 more classes in this area

  • Blood & clotting

    19.4%
    Factor Xa inhibitor10.4%
    Eliquis93%Xarelto7%
    Part D<11 patients
    P2Y12 inhibitor8%
    Prasugrel Hcl36%Brilinta35%Clopidogrel29%
    Part D≥16 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    7.2%
    SGLT2 inhibitor3.5%
    Farxiga100%
    Part D≥14 patients
    Potassium supplement3%
    Potassium Chloride100%
    Part D≥11 patients

    + 1 more class in this area

Where care is delivered (Part B)65.8% facility · 34.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”